PORTLAND, Ore., June 18, 2025--(BUSINESS WIRE)--Diabetomics has been rebranded Modality Dx. Founded by Dr. Srinivasa Nagalla, Modality Dx is an innovator in rapid test technologies for risk assessment ...
According to a 2020 European Commission study, 1 in 17 people affected by a rare disease during their lifetime and a path to a diagnosis that lasts on average five years. This new partnership will ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results